Trial Information

Treating your Crohn's disease doesn't have to be a solo act.

Do you have Crohn’s disease?

You may be eligible to participate in the OPERA study - a clinical research study evaluating whether an investigational drug (study drug) safety and effectively treats Crohn’s disease compared to placebo (looks like the study drug but does not contain any active medication).

The study drug is intended to reduce the inflammation of the intestines, which causes many of the symptoms you may be experiencing.

The OPERA study will also evaluate the best does of the study drug for treating Crohn’s disease.

You may be eligible to participate if you:

Are between 18 and 75 years old
Have active Crohn’s disease
Have failed to respond to anti-TNF treatments (e.g. Remicade, Humira, Cimzia)
Have failed or are intolerant to immunosuppressants (e.g. methotrexate, azathioprine, 6-mercaptopurine)

Patient Exclusion Criteria:

Under age 18

Participation in the study is voluntary.

To find out if the OPERA study is right for you, please contact the site below:
www.wakeresearch.com

Wake Research Associates
3100 Duraleigh Road
Suite 304
Raleigh, NC 27612
Phone: 919-781-2514
Email: WRAnews@wakeresearch.com

View Map

Research Center Information: Wake Research Associates

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:
Message:

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.